We conducted a study of the Baha bone-anchored hearing aid system to quantify the diff erence between (1) hearing thresholds obtained through preoperative testing methods with the Baha sound processor attached to three diff erent bone-conduction testing devices and (2) thresholds obtained postoperatively with the sound processor attached to a surgically placed osseointegrated titanium implant. Twenty-three patients underwent free-fi eld testing in four situations: with the Baha sound processor attached to (1) the Baha Testband (transcutaneous transmission), (2) the Baha Soft band (transcutaneous transmission), (3) a test rod (bone conduction via the teeth), and (4) the osseointegrated implant (percutaneous transmission). Th e main outcome measure was the result of a comparison of the thresholds obtained with the three preoperative test methods and those obtained with the osseointegrated implant. We found that aided thresholds obtained with the osseointegrated implant were signifi cantly better (p < 0.05) than those obtained with the three preoperative test methods. Th e degree of superiority increased with higher frequencies. We conclude that thresholds of 1 to 18 dB better than those obtained by preoperative test methods can be expected postoperatively with the osseointegrated implant. Th e damping eff ect of sound transmission via the teeth or transcutaneously must be accounted for in making predictions of postoperative outcome.
Introduction
Bone-conduction hearing devices transmit amplifi ed sound through the skull, bypassing an impaired or diseased external or middle ear. Th ese devices are indicated for patients with chronically discharging ears, ossicular disease, and congenital malformations of the external or middle ear not amenable to surgical correction. More recently, they have been used as an alternative to contralateral routing of sound (CROS) aids in patients with single-sided deafness.
Conventional transcutaneous bone-conduction hearing aids have two main disadvantages: (1) they can be very uncomfortable to wear because of the constant pressure applied to the mastoid region, and (2) the acoustic signal is attenuated and distorted as it passes through the skin and soft tissues. In hopes of overcoming these drawbacks, researchers in Sweden conceived a direct bone-conduction device in 1977. Aft er refi nements, this device-called the bone-anchored hearing aid (trade name: Baha)-became commercially available in 1987, and it has since been employed increasingly worldwide. 1 (Th e Baha was developed by Entifi c Medical Systems of Göteborg, Sweden, which was subsequently acquired by Cochlear Ltd. of Sydney, Australia.) Th e Baha is a direct bone-conduction device that contains a surgically placed osseointegrated titanium implant and a bone-anchored sound processor. A bodyworn device provides a stronger output force level for patients with more severe mixed hearing losses. 2 Prior to Baha implantation, a detailed audiologic assessment is imperative to identify patients in whom the Baha will likely be successful. Th e minimum requirement includes pure-tone audiometry and speech audiometry. In addition, preoperative testing can be done by simulating implantation; one means of accomplishing this is with the sound processor attached to a plastic snap methods to predict the fi nal postoperative outcome and thus provide more informed rehabilitation counseling.
Patients and methods
Our study group was made up of 23 patients-9 men and 14 women, aged 45 to 86 years at the time of testingwho had been fi tted with a Baha. Th eir impairments included a pure conductive hearing loss in 13 patients, a mixed loss with a variable sensorineural component in 7 patients, and a single-sided sensorineural loss in 3 patients. Th eir range of pathologies included chronic middle ear disease, otitis externa, otosclerosis, and congenital aural defects. Each patient's specifi c sound processor had been prescribed on the basis of his or her average bone-conduction threshold; there were 12 Compact sound processors, 5 Classic processors, 4 Cordelle processors, and 2 Divino processors (table 1) .
All patients underwent objective postoperative evaluations in our clinic as recommended by the manufacturer. 2 Free-fi eld testing is the test of choice; it is recommended by the manufacturer in this clinical situation, it is widely used by audiologists to test aided thresholds, and it tests both the patient and the device as a whole system. Pure tones were generated by a standard audiometer in a sound-proof booth and presented via a loudspeaker placed 1.5 m from the patient on the side of the osseointegrated implant.
All patients used their own personal Baha sound processor for all tests. All sound processors were kept at the patient's normal daily volume and other settings at all times, and they were not adjusted for diff erent test situations. Each threshold was recorded as a sound pressure level (dBAid, where A = aided) on a sound pressure meter. Th e meter was held 2 cm horizontally from the microphone for every threshold recorded. Calibration of the free-fi eld system was therefore performed on an individual basis. Th is method ensured that calibration could be performed when the microphone was in a diff erent position, such as when the sound processor was attached to the test rod between the teeth or when the body-worn Cordelle sound processor was used. Th resholds were determined at frequencies of 0.5, 1, 2, 4, and 6 KHz, per the British Society of Audiology guidelines.
Four diff erent listening situations were tested, one each with the Baha sound processor coupled to:
• the osseointegrated implant (dBAid-O); • the Baha Testband (dBAid-T), with the snap con-connector on a Baha Testband. 2 Th e snap connector is placed over the mastoid process, and it allows for ambulatory evaluation of the device in diff erent surroundings. An alternative to the Testband is the Baha Soft band, an elastic headband with an adjustable Velcro fastening and a plastic snap connector sewn into the band; it can be used in children who are not yet old enough for surgery, in adults who are awaiting surgery or awaiting fi tting of a sound processor, and as a method of preoperative assessment. Finally, preoperative testing can be done with a test rod that is pressed against the mastoid or held between the teeth to facilitate the patient's perception of bone-conducted sound.
Although the Testband and Soft band are useful adjuncts to basic audiologic assessment, both transmit sound energy through the skin and soft tissues, thereby damping the sound in exactly the same way that a conventional transcutaneous bone-conduction hearing aid does. 3 Likewise, the test rod also attenuates sound because the overall sensitivity of the teeth to bone-conducted sound is less than that of an osseointegrated implant. 4 Also, the quality of transmitted sound can be aff ected by the adapter to which the transducer is connected. 4 For all these reasons, both the gain and the quality of the perceived sound during preoperative assessment might be misleading.
Studies carried out during the development of Baha in the 1980s indicated that skin penetration resulted in an improvement in the hearing threshold of 10 to 20 dB. [5] [6] [7] [8] [9] However, most of these tests were carried out with impedance measurement apparatus and other laboratory audiologic techniques. Recently, Pfi ff ner et al proposed that the preoperative bone-conduction thresholds of the better-hearing ear should be used to estimate the postoperative aided free-fi eld thresholds. 10 However, such a measurement does not take into account the subjective assessment of a patient's suitability for surgery, which can be assessed using preoperative tests. A group led by Off eciers investigated the Baha product that is in widespread use today in a setting relevant to clinical practice. 11, 12 Th ey found signifi cant diff erences in the range of 5 to 20 dB for frequencies of 1 to 4 kHz between preoperative test situations and the fi nal postoperative result.
Th e aim of this study was to quantify the audiometric diff erences between pre-and postoperative hearing thresholds using the Baha system and standard audiology equipment set up according to the manufacturer's instructions in a clinical setting. Our goal was to enable audiologists and surgeons to use preoperative testing nector applied to the mastoid process on the side of the osseointegrated implant and within 2 cm of the implant and posterior to the pinna;
• the Baha Soft band (dBAid-S), with the snap connector applied to the mastoid process on the side of the osseointegrated implant and within 2 cm of the implant and posterior to the pinna; and
• the Baha test rod (dBAid-R), placed between the upper 2 and lower 2 incisors.
All tests were performed during a single session for each patient and in the order indicated above without any changes being made to the gain setting on the sound processor.
Th resholds were compared with each other using three-way analysis of variance (ANOVA): by the number of methods (4), the number of frequencies (5) , and the number of patients (23). Th e Scheff é test for multiple comparisons was used to compare pairs of methods or frequencies. Th e same analysis was carried out on subgroups of patients according to the predominant pattern of hearing loss (conductive, mixed, or singlesided deafness). Th e date of the most recent unaided bone-conduction thresholds varied considerably among patients, and these values were therefore excluded from the statistical analysis.
Results
Th e sound pressure meter recorded thresholds between a minimum of 30 dB and maximum of 100 dB. For the purpose of statistical analysis of the results, thresholds that were better or worse than these levels were arbi- trarily assigned values of 30 and 100 dBAid, respectively.
Th e mean threshold for the entire study population in each listening situation at each frequency is shown in fi gure 1. Th e diff erence between the mean threshold obtained with the osseointegrated implant and that obtained with the three test methods (dBAid-T minus dBAid-O; dBAid-S minus dBAid-O; and dBAid-R minus dBAid-O) was then calculated as a function of frequency (fi gure 2, table 2). ANOVA was used to assess the data further. Th e residuals were normally distributed. Th e thresholds obtained with the osseointegrated implant were found to be signifi cantly better (95% confi dence level) than those obtained with the Testband at 1, 2, 4, and 6 kHz and signifi cantly better than those obtained with both the Soft band and the test rod at 2, 4, and 6 kHz (table  2) . Also, the mean diff erence in threshold over all 5 frequencies was calculated for each test method to give an overall estimate of the improvement that could be expected with each method (table 2) .
Th e apparent diff erence in the relative sensitivities of the test methods themselves, evident in fi gure 2, was analyzed by calculating the diff erences in threshold between methods as a function of frequency. Th e only statistically signifi cant diff erence was the improved performance of the Soft band relative to the test rod at 4 kHz (p = 0.03).
No signifi cant diff erences in mean thresholds with each method were found in any subgroup classifi ed according to the type of hearing loss (i.e., conductive, mixed, or single-sided deafness) at any frequency (table 3) .
Discussion
Our results show that perceived sound obtained postoperatively with the osseointegrated implant is better than that obtained with any of the preoperative test methods that can be used to assess patients' suitability for a Baha implant. Th e improvement in aided hearing threshold becomes greater at higher frequencies.
Previous research by Stenfelt and Håkansson 4 and by Håkansson et al 5 has shown that below 500 Hz, the skin-covered mastoid, the teeth, and the osseointegrated implant have the same sensitivity to transmitted sound. At around 500 Hz, the force transmitted to the skull begins to become diminished by the damping eff ect of the skin, soft tissues, and teeth. Th is damping eff ect increases as the frequency increases (although skin thickness has not been shown to have any infl uence between 250 Hz and 4 kHz). 13 As the frequency increases, a corresponding deterioration in the sensitivity of the skin-covered mastoid and teeth relative to the osseointegrated implant is seen; this is manifested by a progressive disparity between thresholds obtained with the implant and those obtained with the preoperative test methods. Th erefore, at low frequencies, preoperative testing provides a reasonable indication of the gain that can be expected with the osseointegrated implant. At high frequencies, however, the results become far more misleading in terms of predicting postoperative outcome for patients with reasonable unaided high-frequency thresholds (for patients with severe to profound high-frequency loss, the disparity is irrelevant). Th e trend illustrated by our data broadly corresponds with the published literature on conventional versus percutaneous bone conduction. 1, [5] [6] [7] [8] [9] Yet the Baha and the long-established bone-conduction hearing aids have diff erent resonant frequency characteristics, and therefore the results of these earlier studies are not directly comparable to the results obtained with the Baha sound processor coupled to transcutaneous devices. 14 In more recent work, investigators have started to study the eff ect of the type of coupling mechanism on Baha characteristics. For example, Majdalawieh et al 15 found little diff erence between the skull vibrations generated by coupling Baha to an implant and to a Testband on a dry skull, although this obviously does not represent a real clinical situation. More relevant is the transcranial attenuation of vibrations measured in a live patient with bilateral osseointegrated implants. Th is was evidenced in our study by the fi nding that thresholds were worse when the Baha was attached to the test rod held between the teeth, which have almost a direct coupling with the skull bone, than when the Baha was coupled to the implant. Majdalawieh et al also found that the volume setting of the sound processor had little eff ect on vibration output overall. 15 Th e results of a study by Hodgetts et al suggested that headband tension does not adversely aff ect the results. 16 Th ey did not fi nd any signifi cant changes in output force levels when the Soft band tension was varied from 2 to 5 N, indicating that a comfortably snug Soft band fi tting does not confer any disadvantage in sound delivery over a tighter fi tting one. In our study, no consideration was given to Soft band tightness and thus force delivery because we attempted to conduct our investigation by remaining true to real clinical situations.
Other attempts have been made to use preoperative audiometry with the sound processor attached to transcutaneous devices to predict fi nal postoperative Baha results. As mentioned, the group led by Off eciers found signifi cant diff erences in the range of 5 to 20 dB at frequencies of 1 to 4 kHz between the Baha coupled to the osseointegrated implant and to the Testband or Soft band. 11, 12 Th ey also found a diff erence in speech reception threshold of 4 to 7 dB in their group of 10 previously implanted adults who were fi tted with the Compact sound processor. Our free-fi eld audiometry results were very similar. In addition, we also assessed the predictive value of the test rod held between the teeth. In looking at patients with single-sided deafness, Snapp et al showed that there was no signifi cant diff erence between preoperative speech-in-noise testing with the Baha Cordelle II headband stimulator and the postoperative results with the implanted device. 17 Th ey therefore advocate the use of speech-in-noise measures as an accurate way of predicting overall benefi t to the patient prior to implantation. However, all of these studies 11, 12, 17 and our own were based on the assumption that transcutaneous thresholds are not aff ected by the surgical placement of an implant that undergoes osseointegration, and this assumption may not be entirely valid. Ideally, a prospective study comparing true preoperative transcutaneous and postoperative percutaneous bone-conduction thresholds needs to be conducted. Our results demonstrate a diff erence between the relative sensitivities of the preoperative test methods themselves. Figure 2 shows that the gain achieved with the Soft band was closest to that of the osseointegrated implant at all test frequencies. At low frequencies, the Testband was the least sensitive method, while at high frequencies the test rod was the least sensitive. Th is suggests that the Soft band should be used for preoperative assessment whenever possible. Nevertheless, the only diff erence among the three test methods that was statistically signifi cant was the degree of improvement with the Soft band relative to the test rod at 4 kHz. In the speech frequencies, the minimal diff erences in threshold among test methods might be attributable to test-retest variability. Off eciers' group did not fi nd any statistically signifi cant diff erence between the Testband and the Soft band, and therefore they advocated the use of the Soft band for preoperative assessment because it is more comfortable. 11, 12 In our study, the intra-and interpatient scattering seen in the recorded results can be partly explained by factors over which we had no control. For example, the sound perceived by a particular patient at a particular sound intensity depends on the impedance of the mechanical system as a whole and on the natural resonant frequencies of the component parts, which in this instance includes the sound processor itself and any tissues or materials between it and the cochlea. Th ere is natural variation in the elasticity and weight of healthy human tissue; the presence of pathology introduces further diversity of relevance-for example, a shift in the resonant frequency of a diseased middle ear.
Our study design itself created error in the results because free-fi eld testing is subject to great variability, and it does not take speech discrimination into account. Nevertheless, it is recommended by the manufacturer for objective postoperative evaluation, and it is widely used by audiologists to test aided thresholds, so its use is consistent with everyday clinical practice. Moreover, it tests the patient and device as a whole system, it allows patients to serve as their own controls, and it is independent of linguistic issues such as non-native language or neurologic insults to speech comprehension.
Our fi ndings would have been strengthened if our study design had included speech audiometry. Speech recognition scores and speech intelligibility in noise as assessed by the three preoperative test methods and by the osseointegrated implant would have contributed valuable information to preoperative prediction of postoperative outcome. Some inaccuracy in our results was inevitable because sound pressure levels lower than 30 dB and higher than 100 dB could not be recorded. Th e main implication of this is seen in the low-frequency data, where there were many thresholds around 30 dB. First, the largely similar thresholds among the three methods at the low frequencies might have represented artifact, which might have masked greater variations that would have been evident if the lower thresholds could have been recorded. Second, background noise below 30 dB might have been present in the sound-proof booth, and this might have contaminated the threshold measurements. As stated earlier, thresholds that were better than 30 dB or worse than 100 dB were assigned values of 30 and 100 dBAid, respectively. Most of the patients with a threshold better than 30 dB with the osseointegrated implant exhibited thresholds worse than 30 dB, which registered on the sound pressure meter with the three test methods.
Conversely, at the other end of the scale, patients whose test method thresholds were worse than 100 dB generally had a recordable threshold with the osseointe- grated implant. Th erefore, although the mean diff erences between the implant and each of the three test methods were not exact, it seems reasonable to assume that the values indicated in table 2 represent the minimum differences, and as such the postoperative outcome might have, in fact, been better than what would be expected from these fi gures. More accurate results could be obtained with a more sensitive sound pressure meter or by testing a much larger population and excluding any results outside the recordable range.
In conclusion, the data we obtained are benefi cial as a guide for patients, audiologists, and surgeons in terms of predicting a likely outcome aft er surgical implantation of the Baha. Th resholds of 1 to 18 dB (table 2) better than those obtained with the preoperative test methods can be expected postoperatively. All of the test methods available are fairly representative of postoperative thresholds at low frequencies, but they become progressively disparate from them at higher frequencies. We believe that this fi nding should be taken into consideration, along with other factors, in the assessment of patients for a Baha, particularly those whose suitability for this device is borderline.
